151 related articles for article (PubMed ID: 30936073)
1. Exosomal miRNA Cargo as Mediator of Immune Escape Mechanisms in Neuroblastoma.
Schmittgen TD
Cancer Res; 2019 Apr; 79(7):1293-1294. PubMed ID: 30936073
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms.
Neviani P; Wise PM; Murtadha M; Liu CW; Wu CH; Jong AY; Seeger RC; Fabbri M
Cancer Res; 2019 Mar; 79(6):1151-1164. PubMed ID: 30541743
[TBL] [Abstract][Full Text] [Related]
3. Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs.
Haug BH; Hald ØH; Utnes P; Roth SA; Løkke C; Flægstad T; Einvik C
Anticancer Res; 2015 May; 35(5):2521-30. PubMed ID: 25964525
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA analysis of Natural Killer cell-derived exosomes: the microRNA let-7b-5p is enriched in exosomes and participates in their anti-tumor effects against pancreatic cancer cells.
Di Pace AL; Pelosi A; Fiore PF; Tumino N; Besi F; Quatrini L; Santopolo S; Vacca P; Moretta L
Oncoimmunology; 2023; 12(1):2221081. PubMed ID: 37304055
[TBL] [Abstract][Full Text] [Related]
5. miR-221-5p and miR-186-5p Are the Critical Bladder Cancer Derived Exosomal miRNAs in Natural Killer Cell Dysfunction.
Huyan T; Gao L; Gao N; Wang C; Guo W; Zhou X; Li Q
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499501
[TBL] [Abstract][Full Text] [Related]
6. NK Cell-derived Exosomes From NK Cells Previously Exposed to Neuroblastoma Cells Augment the Antitumor Activity of Cytokine-activated NK Cells.
Shoae-Hassani A; Hamidieh AA; Behfar M; Mohseni R; Mortazavi-Tabatabaei SA; Asgharzadeh S
J Immunother; 2017 Sep; 40(7):265-276. PubMed ID: 28622272
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy-induced overexpression of exosomal miRNA-378a-3p in cancer cells limits natural killer cells cytotoxicity.
Briand J; Garnier D; Nadaradjane A; Clément-Colmou K; Potiron V; Supiot S; Bougras-Cartron G; Frenel JS; Heymann D; Vallette FM; Cartron PF
Epigenomics; 2020 Mar; 12(5):397-408. PubMed ID: 32267172
[No Abstract] [Full Text] [Related]
8. Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasis.
Wang X; Luo G; Zhang K; Cao J; Huang C; Jiang T; Liu B; Su L; Qiu Z
Cancer Res; 2018 Aug; 78(16):4586-4598. PubMed ID: 29880482
[TBL] [Abstract][Full Text] [Related]
9. Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma.
Burga RA; Yvon E; Chorvinsky E; Fernandes R; Cruz CRY; Bollard CM
Clin Cancer Res; 2019 Jul; 25(14):4400-4412. PubMed ID: 31010834
[TBL] [Abstract][Full Text] [Related]
10. Human exosomal placenta-associated miR-517a-3p modulates the expression of PRKG1 mRNA in Jurkat cells.
Kambe S; Yoshitake H; Yuge K; Ishida Y; Ali MM; Takizawa T; Kuwata T; Ohkuchi A; Matsubara S; Suzuki M; Takeshita T; Saito S; Takizawa T
Biol Reprod; 2014 Nov; 91(5):129. PubMed ID: 25273530
[TBL] [Abstract][Full Text] [Related]
11. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.
Warnecke-Eberz U; Chon SH; Hölscher AH; Drebber U; Bollschweiler E
Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748
[TBL] [Abstract][Full Text] [Related]
12. Exosomes containing miR-1469 regulate natural killer cells by targeting CD122 in non-segmental vitiligo.
Wei Y; Zhou T; Pan R; Nie X; Liu Z; Shi Z; Zeng Y; Zhang R; Deng Y; Li D
J Dermatol Sci; 2024 Feb; 113(2):42-50. PubMed ID: 38307771
[TBL] [Abstract][Full Text] [Related]
13. RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancer.
Cheng WC; Liao TT; Lin CC; Yuan LE; Lan HY; Lin HH; Teng HW; Chang HC; Lin CH; Yang CY; Huang SC; Jiang JK; Yang SH; Yang MH; Hwang WL
Int J Cancer; 2019 Oct; 145(8):2209-2224. PubMed ID: 30980673
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275/AXIN2 in natural killer cells.
Ou Z; Lu Y; Xu D; Luo Z
Front Immunol; 2023; 14():1271603. PubMed ID: 38035113
[TBL] [Abstract][Full Text] [Related]
15. HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape.
Han Q; Zhao H; Jiang Y; Yin C; Zhang J
Cells; 2019 Jun; 8(6):. PubMed ID: 31181729
[TBL] [Abstract][Full Text] [Related]
16. Oral cancer-derived exosomal NAP1 enhances cytotoxicity of natural killer cells via the IRF-3 pathway.
Wang Y; Qin X; Zhu X; Chen W; Zhang J; Chen W
Oral Oncol; 2018 Jan; 76():34-41. PubMed ID: 29290284
[TBL] [Abstract][Full Text] [Related]
17. A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma.
Shohet JM; Ghosh R; Coarfa C; Ludwig A; Benham AL; Chen Z; Patterson DM; Barbieri E; Mestdagh P; Sikorski DN; Milosavljevic A; Kim ES; Gunaratne PH
Cancer Res; 2011 Jun; 71(11):3841-51. PubMed ID: 21498633
[TBL] [Abstract][Full Text] [Related]
18. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
19. Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells.
Zhu L; Oh JM; Gangadaran P; Kalimuthu S; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Front Immunol; 2018; 9():824. PubMed ID: 29740437
[TBL] [Abstract][Full Text] [Related]
20. A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells.
Zhao Z; Ma X; Shelton SD; Sung DC; Li M; Hernandez D; Zhang M; Losiewicz MD; Chen Y; Pertsemlidis A; Yu X; Liu Y; Du L
Oncotarget; 2016 Nov; 7(48):79372-79387. PubMed ID: 27764804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
